These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18545248)

  • 21. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005.
    Sauer M; Meissner B; Fuchs D; Gruhn B; Kabisch H; Erttmann R; Suttorp M; Beilken A; Luecke T; Welte K; Grigull L; Sykora KW
    Bone Marrow Transplant; 2009 Mar; 43(5):375-81. PubMed ID: 18850023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective longitudinal multicenter study of coagulation in pediatric patients undergoing allogeneic stem cell transplantation.
    Brandão LR; Kletzel M; Boulad F; Kurtzberg J; Maloney K; Fligman I; Sison CP; Dimichele D
    Pediatr Blood Cancer; 2008 Jun; 50(6):1240-6. PubMed ID: 18273869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transplants in Adult ALL--? Allo for everyone.
    Goldstone AH
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):7-10. PubMed ID: 19147069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Autologous hematopoietic stem cell transplantation].
    Nemet D
    Acta Med Croatica; 2009 Jun; 63(3):219-25. PubMed ID: 19827349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-endocrine late complications in children after allogeneic haematopoietic SCT.
    Faraci M; Békássy AN; De Fazio V; Tichelli A; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S49-57. PubMed ID: 18545245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic transplantation for pediatric acute lymphoblastic leukemia: the emerging role of peritransplantation minimal residual disease/chimerism monitoring and novel chemotherapeutic, molecular, and immune approaches aimed at preventing relapse.
    Pulsipher MA; Bader P; Klingebiel T; Cooper LJ
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):62-71. PubMed ID: 19147081
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis.
    Borgmann A; von Stackelberg A; Hartmann R; Ebell W; Klingebiel T; Peters C; Henze G;
    Blood; 2003 May; 101(10):3835-9. PubMed ID: 12732501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haploidentical SCT in children: an update and future perspectives.
    Lang P; Handgretinger R
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S54-9. PubMed ID: 18978746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma.
    Maloney D
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S35-S36. PubMed ID: 18724296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retrospective analysis of relapsed or primary refractory childhood lymphoblastic lymphoma in Japan.
    Mitsui T; Mori T; Fujita N; Inada H; Horibe K; Tsurusawa M;
    Pediatr Blood Cancer; 2009 May; 52(5):591-5. PubMed ID: 19156862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.
    Wahlin A; Billström R; Björ O; Ahlgren T; Hedenus M; Höglund M; Lindmark A; Markevärn B; Nilsson B; Sallerfors B; Brune M
    Eur J Haematol; 2009 Aug; 83(2):99-107. PubMed ID: 19385987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Second allogeneic stem cell transplantation in myeloid malignancies.
    Hartwig M; Ocheni S; Asenova S; Wiedemann B; Zabelina T; Ayuk F; Kabisch H; Erttmann R; Kröger N; Zander AR; Bacher U
    Acta Haematol; 2009; 122(4):185-92. PubMed ID: 19887774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haematopoietic SCT for children and adolescents with relapsed and refractory Hodgkin's lymphoma.
    Claviez A; Sureda A; Schmitz N
    Bone Marrow Transplant; 2008 Oct; 42 Suppl 2():S16-24. PubMed ID: 18978738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the pretransplantation phase of the hemopoietic stem cell program in a tertiary hospital.
    Márquez Malaver FJ; Espigado Tocino I; Balsalobre López P; Carmona González M; Parody Ruiz-Berdejo R; Perez-Hurtado de Mendoza JM; Urbano Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3099-101. PubMed ID: 19010206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission.
    Larson RA
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):11-6. PubMed ID: 19147070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome after reduced-intensity conditioning allogeneic SCT for AML in first complete remission: comparison of two regimens.
    Cahu X; Mohty M; Faucher C; Chevalier P; Vey N; El-Cheikh J; Guillaume T; Furst S; Delaunay J; Ayari S; Moreau P; Gastaut JA; Harousseau JL; Blaise D
    Bone Marrow Transplant; 2008 Nov; 42(10):689-91. PubMed ID: 18679370
    [No Abstract]   [Full Text] [Related]  

  • 40. 28 years of high-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures.
    Ladenstein R; Pötschger U; Hartman O; Pearson AD; Klingebiel T; Castel V; Yaniv I; Demirer T; Dini G;
    Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S118-27. PubMed ID: 18545256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.